Myosin Cardiac Treatment Revolution
Myosin inhibitors hold great promise in the treatment of hypertrophic cardiomyopathy (HCM). Their targeted approach has been specifically designed to address the unique needs of HCM patients, unlike other medications that were developed for general heart conditions.
